Master of Biotechnology - 2018

Postgraduate - Course

Commencement year

This course entry applies to students commencing this course in 2018 and should be read in conjunction with information provided in the 'Faculty information' section of this Handbook by the Medicine, Nursing and Health Sciences.

Unit codes that are not linked to their entry in the Handbook are not available for study in the current year.

Course code


Credit points


Abbreviated title




Managing faculty

Medicine, Nursing and Health Sciences


Professor Peter Currie (Course Coordinator)
Dr Chau Khuong (Assistant Course Coordinator)

Admission and fees


Course progression map

M6030 (pdf)

Course type

Master by coursework

Standard duration

2 years FT, 4 years PT

This course normally takes 2 years full-time to complete but if you have relevant entry qualifications you may receive credit and be able to complete the course in 1 year full-time, or part-time equivalent.

You have a maximum of 6 years to complete this course including any periods of intermission and suspension, and must be continuously enrolled throughout.

Mode and location

On-campus (Clayton)


Master of Biotechnology


The Master of Biotechnology integrates biotechnology and entrepreneurship through a range of multidisciplinary coursework, research and work-integrated units in modern areas of studies.

In the first year (Part A) of the course, students will be taught theoretical knowledge and practical skills in contemporary biotechnology-related topics, and the processes involved in obtaining research funding and translating biomedical products from lab to life.

In the second year (Part B) of the course, students who have 70% and above average in their first-year studies will have the opportunity to undertake either a 3-month or 6-month industry placement in pharmaceutical, medical device, life science and/ or regulatory organisation. Students will also have the option to undertake a research project, where they will work closely with experts in a specialised area of research to advance knowledge of human diseases, and explore therapeutic targets for the prevention and treatment of these conditions. In addition, Part B offers a range of coursework electives in interdisciplinary field of pioneering developments in biotechnology research and enterprise.


These course outcomes are aligned with the Australian Qualifications Framework level 9 and Monash Graduate AttributesAustralian Qualifications Framework level 9 and Monash Graduate Attributes (

Upon successful completion of this this course, it is expected that you will be able to:

  1. demonstrate mastery in theoretical knowledge in major contemporary fields of biotechnology and its applications
  2. differentiate between the processes involved in the development, regulation, commercialisation and marketing of biotechnological products
  3. identify the ethical issues relating to research and the research question in the field of biotechnology and where, appropriate, apply ethical principles to the conduct of research within this field
  4. initiate new or innovative research informed approaches to resolving practical challenges within the field of medical biotechnology
  5. demonstrate proficiency in laboratory based technologies and techniques fundamental to biotechnological research
  6. critically appraise and interpret the implications of data arising from these technologies and techniques
  7. plan, justify and implement research in the field of medical biotechnology
  8. apply effective and strategic problem-solving, organisational and teamwork skills to the field of biotechnology
  9. effectively implement and evaluate technological advancements in biotechnology within workplace settings.


The course is structured in two parts: Part A. Core Biotechnology studies and Part B. Application studies. All students complete Part A. Depending upon prior qualifications, you may receive credit for Part B.

Note: If you are eligible for credit for prior studies you may elect not to receive the credit.

Part A. Core biotechnology studies

These studies present theoretical knowledge in key areas of biotechnology and its applications. You will gain a critical understanding of the designs and methods used in undertaking medical research, and the opportinities and challenges involved in the commercialisation of biotechnology.

Part B. Application studies

In these studies, you will focus on the application of advanced biotechnology practice. You will consolidate your skills, and knowledge and demonstrate your mastery through either a research project and/ or an industry placement program.


The course comprises 96 points structured into two parts: Part A. Core Biotechnology (48 points) and Part B: Application Studies (48 points).

If you are admitted at:

  • entry level 1 you complete 96 points, comprising Parts A and B.
  • entry level 2 you complete 48 points, comprising Part A.

Note: If you are eligible for credit for prior studies you may elect not to receive the credit.

Units are 6 credit points unless otherwise stated.

Part A. Core biotechnology studies (48 points)

You must complete:

  • BRM5011 Foundations for medical biotechnology and its applications
  • BRM5012 Techniques in medical biotechnology: genomics, proteomics and bioinformatics
  • BRM5013 Techniques in medical biotechnology: Imaging, iPS cells, cell and gene therapies
  • GEN5010 Advanced genetics and biotechnology
  • BMS5005 Regenerative medicine and stem cells
  • BEX5411 Creativity and entrepreneurship
  • BMS5007 Biotechnology: Commercialising biomedical science
  • XXX5xxx Therapeutic approaches in regenerative medicine

Part B. Application studies (48 points)

You must complete either a. or b. below.

a. Research pathway:

  • XXX5xxx Research project (36 points)
  • XXX5xxx Industry placement - three months (12 points)* or two units from the elective list below

b. Coursework pathway:

  • XXX5xxx Industry placement - six months (24 points) *
  • four units from the elective list below

* In order to be eligible for the industry placement, you need to have an average of more than 70 per cent in your core biotechnology studies (Part A). If you do not meet this requirement, then you must undertake the research project and two elective units.

Elective list

  • BFF5904 New venture finance
  • MEC5889 Medical device technologies
  • MTE5885 Biomaterials and Biomechanics
  • XXX5xxx Biotechnologies of the future
  • XXX5xxx Organoids, in vitro and in disease modelling

Alternative exits

You may exit this course early and apply to graduate with the following award, provided you have satisfied the requirements for that award during your enrolment in this master's course:

  • Graduate Diploma of Biotechnology after successful completion of Part A.

Progression to further studies

Students entering at entry level 1 completing the research project (36 points) in Part B may be eligible to progress to a higher degree by research program.